Cerevel Therapeutics Holdings Inc
-
Health News
‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights
[ad_1] There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health…
Read More » -
Health News
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin…
Read More » -
Business
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1] A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on…
Read More »